FMP
Biofrontera Inc.
BFRI
NASDAQ
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
0.979 USD
-0.0215 (-2.2%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Dr. Hermann Luebbert Ph.D.
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
exchange
NASDAQ
Description
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
CIK
0001858685
ISIN
US09077D2099
CUSIP
09077D100
Address
120 Presidential Way
Phone
781 245 1325
Country
US
Employee
83
IPO Date
Oct 29, 2021
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
BFRI Financial Summary
CIK
0001858685
Exchange
NASDAQ
Industry
Drug Manufacturers -...
Sector
Healthcare
CUSIP
09077D100
ISIN
US09077D2099
Country
US
Price
0.98
Beta
0.51
Volume Avg.
2.97M
Market Cap
7.58M
Shares
-
52-Week
0.61-3.9
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
0.84
P/B
-
Website
https://www.biofrontera.us.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest BFRI News
It looks like there's no news available.
